{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:28:59Z","timestamp":1793035739434,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"am","delay-in-days":297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006485","name":"National Institute of Genetic Engineering and Biotechnology","doi-asserted-by":"crossref","award":["90\/449"],"award-info":[{"award-number":["90\/449"]}],"id":[{"id":"10.13039\/501100006485","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["90001816"],"award-info":[{"award-number":["90001816"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ijbiomac.2018.03.034","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T01:47:13Z","timestamp":1520473633000},"page":"1267-1278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Generation and screening of efficient neutralizing single domain antibodies (VHHs) against the critical functional domain of anthrax protective antigen (PA)"],"prefix":"10.1016","volume":"114","author":[{"given":"Abbas","family":"Shali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadegh","family":"Hasannia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Gashtasbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Abdous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Shirin","family":"Shahangian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Jalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0005","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.282.22.2104","article-title":"Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax","volume":"282","author":"Friedlander","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00001432-200004000-00004","article-title":"Current status of immunization against anthrax: old vaccines may be here to stay for a while","volume":"13","author":"Turnbull","year":"2002","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0015","first-page":"1554","article-title":"Anthrax toxic complex","volume":"26","author":"Smith","year":"1967","journal-title":"Fed. Proc."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/iai.49.2.291-297.1985","article-title":"Demonstration of a capsule plasmid in Bacillus anthrasis","volume":"49","author":"Green","year":"1985","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2672.1999.00883.x","article-title":"Sequence, assembly and analysis of pX01 and pX02","volume":"87","author":"Okinaka","year":"1999","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0030","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0035","doi-asserted-by":"crossref","first-page":"20607","DOI":"10.1016\/S0021-9258(17)32036-7","article-title":"Anthrax protective antigen forms oligomers during intoxication of mammalian cells","volume":"269","author":"Milne","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0040","first-page":"1079","article-title":"Stoichiometry of anthrax toxin complexes","volume":"41","author":"Mogridge","year":"2002","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0045","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1073\/pnas.86.7.2209","article-title":"Finkelstein, Anthrax toxin: channel-forming activity of protective antigen in planar phospholipid bilayers","volume":"86","author":"Blaustein","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0050","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/toxins3081004","article-title":"Monoclonal antibody therapies against Anthrax","volume":"3","author":"Chen","year":"2011","journal-title":"Toxins"},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0055","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1128\/IAI.00261-07","article-title":"Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax","volume":"75","author":"Albrecht","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa0810603","article-title":"Raxibacumab for the treatment of inhalational anthrax","volume":"361","author":"Migone","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0065","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/IAI.73.2.795-802.2005","article-title":"A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge","volume":"73","author":"Mohamed","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0070","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1128\/IAI.72.11.6313-6317.2004","article-title":"Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies","volume":"72","author":"Brossier","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0075","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1128\/IAI.00712-06","article-title":"Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity","volume":"74","author":"Vitale","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0080","doi-asserted-by":"crossref","first-page":"14070","DOI":"10.1073\/pnas.1006473107","article-title":"Anthrax toxin-neutralizing antibody reconfigures the protective antigen heptamer into a supercomplex","volume":"107","author":"Radjainia","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.ijbiomac.2018.03.034_bb0085","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.1074\/jbc.M114.627943","article-title":"A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits Anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model","volume":"290","author":"Moayeri","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.03.034_bb0090","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1046\/j.1365-2672.1999.00890.x","article-title":"Anthrax toxin fusion proteins for intracellular delivery of macromolecules","volume":"87","author":"Leppla","year":"1999","journal-title":"J. Appl. Microbiol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.03.034_bb0095","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1476-5381.2009.00190.x","article-title":"Therapeutic antibodies: successes, limitations and hopes for the future","volume":"157","author":"Chames","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5604\/17322693.1000334","article-title":"Variable fragments of heavy chain antibodies (VHHs): a new magic bullet molecule of medicine?","volume":"66","author":"Smolarek","year":"2012","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"issue":"6","key":"10.1016\/j.ijbiomac.2018.03.034_bb0105","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.molimm.2006.05.009","article-title":"The change of the scFv into the Fab format improves the stability and in vivo toxin neutralization capacity of recombinant antibodies","volume":"44","author":"Quintero-Hern\u00e1ndez","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1517\/14712598.5.1.111","article-title":"Nanobodies as novel agents for cancer therapy","volume":"5","author":"Revets","year":"2005","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0115","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.4049\/jimmunol.0903722","article-title":"Novel promiscuous class of camelid single-domain antibody contributes to the antigen-binding repertoire","volume":"184","author":"Deschacht","year":"2010","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2018.03.034_bb0120","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.4155\/tde.13.87","article-title":"Novel therapy based on camelid nanobodies","volume":"4","author":"Unciti-Broceta","year":"2013","journal-title":"Ther. Deliv."},{"issue":"41","key":"10.1016\/j.ijbiomac.2018.03.034_bb0125","doi-asserted-by":"crossref","first-page":"21596","DOI":"10.1074\/jbc.M116.749184","article-title":"Set of single-domain antibodies (VHHs) against the anthrax toxin lethal and edema factors provides a basis for construction of a bispecific agent that protects against anthrax infection","volume":"291","author":"Vrentas","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1128\/CVI.00611-15","article-title":"Adenoviral expression of a Bispecific VHH-based neutralizing agent that targets protective antigen provides prophylactic protection from Anthrax in mice","volume":"23","author":"Moayeri","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0135","first-page":"3","article-title":"Preparation of highly purified human IgG, IgM, and IgA for immunization and immunoanalysis","volume":"2","author":"Nikolayenko","year":"2005","journal-title":"Ukr. Bioorg. Acata"},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.03.034_bb0140","doi-asserted-by":"crossref","first-page":"5.6.1","DOI":"10.1002\/cpbi.3","article-title":"Comparative protein structure modeling using modeller","volume":"54","author":"Webb","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0145","series-title":"Gromacs User Manual. 4.5.4 edn","author":"Van der Spoel","year":"2010"},{"issue":"12","key":"10.1016\/j.ijbiomac.2018.03.034_bb0150","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N log (N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.03.034_bb0155","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","article-title":"Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J. Comput. Phys."},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.03.034_bb0160","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereo chemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"issue":"5","key":"10.1016\/j.ijbiomac.2018.03.034_bb0165","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nprot.2010.32","article-title":"The HADDOCK web server for data-driven bimolecular docking","volume":"5","author":"De Vries","year":"2010","journal-title":"Nat. Protoc."},{"issue":"11","key":"10.1016\/j.ijbiomac.2018.03.034_bb0170","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1128\/IAI.00117-09","article-title":"Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigen","volume":"77","author":"Kelly-Cirino","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0175","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nature02763","article-title":"Crystal structure of a complex between anthrax toxin and its host cell receptor","volume":"430","author":"Santelli","year":"2004","journal-title":"Nature"},{"issue":"28","key":"10.1016\/j.ijbiomac.2018.03.034_bb0180","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1016\/j.vaccine.2012.03.002","article-title":"Human monoclonal antibodies generated following vaccination with ava provide neutralization by blocking furin cleavage but not by preventing oligomerization","volume":"30","author":"Smith","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.ijbiomac.2018.03.034_bb0185","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.mam.2009.08.006","article-title":"Anthrax vaccination strategies","volume":"30","author":"Cybulski","year":"2009","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1172\/JCI0216204","article-title":"Development of an improved vaccine for anthrax","volume":"110","author":"Leppla","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0195","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1128\/IAI.67.4.1860-1865.1999","article-title":"Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin","volume":"67","author":"Varughese","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0200","doi-asserted-by":"crossref","first-page":"30936","DOI":"10.1074\/jbc.M301154200","article-title":"Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody","volume":"278","author":"Rosovitz","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2018.03.034_bb0205","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1128\/AAC.49.8.3414-3420.2005","article-title":"Selection of a macaque fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (pa) of bacillus anthracis by binding to the segment of pa between residues 686 and 694","volume":"49","author":"Laffly","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0210","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1128\/IAI.00261-07","article-title":"Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax","volume":"75","author":"Albrecht","year":"2007","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.ijbiomac.2018.03.034_bb0215","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1128\/AAC.00640-10","article-title":"A chimeric protein that functions as both an anthrax dual-target antitoxin and a trivalent vaccine","volume":"54","author":"Wu","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0220","series-title":"Design and Characterization of Polyvalent Anthrax Toxin Inhibitors, Rensselaer Polytechnic Institute Thesis","first-page":"3299470","volume":"229","author":"Rai","year":"2007"},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0225","doi-asserted-by":"crossref","first-page":"16396","DOI":"10.1016\/S0021-9258(18)42016-9","article-title":"Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen","volume":"267","author":"Molloy","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0230","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1021\/bi972657b","article-title":"Identification of residues lining the anthrax protective antigen channel","volume":"37","author":"Benson","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0235","doi-asserted-by":"crossref","first-page":"10432","DOI":"10.1021\/bi990792d","article-title":"Anthrax protective antigen: prepore-to-pore conversion","volume":"38","author":"Miller","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0240","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1128\/JB.183.6.2111-2116.2001","article-title":"Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin","volume":"183","author":"Mogridge","year":"2001","journal-title":"J. Bacteriol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2018.03.034_bb0245","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/pro.238","article-title":"Domain 4 of the anthrax protective antigen maintains structure and binding to the host receptor CMG2 at low Ph","volume":"18","author":"Williams","year":"2009","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0250","doi-asserted-by":"crossref","first-page":"15493","DOI":"10.1016\/S0021-9258(18)98643-6","article-title":"The carboxyl-terminal end of protective antigen is required for receptor binding and anthrax toxin activity","volume":"266","author":"Singh","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0255","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1128\/CVI.00015-08","article-title":"Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background","volume":"15","author":"Abboud","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2018.03.034_bb0260","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00253-009-2029-1","article-title":"Enhancement of toxin- and virus-neutralizing capacity of single-domain antibody fragments by N-glycosylation","volume":"84","author":"Harmsen","year":"2009","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0265","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijbiomac.2015.02.047","article-title":"A conformation-based phage-display panning to screen neutralizing anti-VEGF VHHs with VEGFR2 mimicry behavior","volume":"77","author":"Shahangian","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.03.034_bb0270","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1039\/C0CS00049C","article-title":"The rational development of molecularly imprinted polymer-based sensors for protein detection","volume":"40","author":"Whitcombe","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0275","series-title":"Structural Bioinformatics","author":"Gu","year":"2009"},{"issue":"6","key":"10.1016\/j.ijbiomac.2018.03.034_bb0280","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nprot.2015.053","article-title":"The Phyre2 web portal for protein modeling, prediction and analysis Kelley","volume":"10","author":"Kelley","year":"2015","journal-title":"Nat. Protoc."},{"issue":"13","key":"10.1016\/j.ijbiomac.2018.03.034_bb0285","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera- a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"1\u20133","key":"10.1016\/j.ijbiomac.2018.03.034_bb0290","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.vetimm.2008.10.299","article-title":"Camelid immunoglobulins and nanobody technology","volume":"128","author":"Muyldermans","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.ijbiomac.2018.03.034_bb0295","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1128\/AAC.00460-13","article-title":"Effect of anthrax immune globulin on response to biothrax (Anthrax vaccine adsorbed) in New Zealand white rabbits","volume":"57","author":"Malkevich","year":"2013","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813017346111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813017346111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T07:00:09Z","timestamp":1758870009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813017346111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":59,"alternative-id":["S0141813017346111"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.03.034","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation and screening of efficient neutralizing single domain antibodies (VHHs) against the critical functional domain of anthrax protective antigen (PA)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.03.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}